Premium
Treatment and outcome of young patients with esophageal cancer in the Netherlands
Author(s) -
van Nistelrooij Anna M.J.,
van Steenbergen Liza N.,
Spaander Ma C.W.,
Tilanus Hugo W.,
van Lanschot J. Jan B.,
Lemmens Valery E.P.P.,
Wijnhoven Bas P.L.
Publication year - 2014
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.23533
Subject(s) - medicine , esophageal cancer , adenocarcinoma , relative survival , stage (stratigraphy) , gastroenterology , cancer , cancer registry , young adult , survival analysis , surgery , paleontology , biology
Background Esophageal cancer is increasingly recognized in younger patients. We compared clinicopathological characteristics, treatment, and survival of patients aged ≤50 years with patients aged >50 years diagnosed with esophageal cancer in the Netherlands. Methods From the nationwide Netherlands Cancer Registry we identified all patients diagnosed with esophageal cancer between January 2000 and January 2011. Proportions were compared using the χ 2 test for categorical variables. Overall and relative survival was calculated. Results Eleven percent of the patients (n = 1,466) were aged ≤50 years and adenocarcinoma was the most common tumor type (73.6%). Grade of tumor differentiation was comparable between both age groups ( P = 0.460) as well as T‐stage ( P = 0.058). Younger patients presented more often with positive lymph nodes (70.1% vs. 66.4%, P = 0.010) and distant metastasis (50.5% vs. 44.7%, P < 0.001) but had surgery more often as compared to older patients: 40.6% versus 37.9%, P = 0.047. There was no significant difference in the 5‐year relative survival between both age groups: 18.1% versus 17.2%, P > 0.05. A subgroup analysis among patients diagnosed with adenocarcinoma revealed similar results. Conclusions Young patients with esophageal cancer present with more advanced disease stage and received more often treatment. However, they show comparable relative survival rates with their older counterparts. J. Surg. Oncol. 2014 109:561–566 . © 2013 Wiley Periodicals, Inc.